0000000000922048

AUTHOR

Novo Salvatore

showing 9 related works from this author

Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclav…

2006

bjective: To evaluate the efficacy of subclavian stenosis percutaneous transfemoral angioplasty (PTA)-treatment in patients with intermittent or complete subclavian steal syndrome (SSS), and coronary-subclavian steal syndrome (C-SSS) after left internal mammary artery-interventricular anterior artery (LIMA-IVA) by pass graft. Methods: We studied 42 patients with coronary subclavian steal syndrome subdivided in two groups; the first group consisted of 15 patients who presented an intermittent vertebral-subclavian steal, while the second group consisted of 27 patients with a complete vertebral-subclavian steal. All patients were treated with angioplasty and stent application and were followed…

Malemedicine.medical_specialtyPercutaneousmedicine.medical_treatmentVertebral arterySubclavian ArteryBalloonSubclavian Steal SyndromeRisk FactorsInternal medicinemedicine.arteryAngioplastymedicineHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesInternal Mammary-Coronary Artery Anastomosishealth care economics and organizationsSubclavian arteryVertebral ArteryAgedChi-Square Distributionmedicine.diagnostic_testbusiness.industryAngiographyUltrasonography DopplerMiddle Agedmedicine.diseaseSurgerybody regionssurgical procedures operativemedicine.anatomical_structureTreatment OutcomePercutaneous angioplasty and stenting of left subclavian artery lesions vertebral and coronary subclavian steal syndrome.Angiographycardiovascular systemCardiologyFemaleStentsCardiology and Cardiovascular MedicinebusinessSubclavian steal syndromeAngioplasty BalloonArteryCardiovascular and interventional radiology
researchProduct

Dyslipidemia management with medical nutrition therapy: current status and perspectives

2013

In Italy, patients with dyslipidennia account for 15-20% of the adult population with major healthcare and socio-economic impact. According to the ESC/EAS guidelines for the management of dyslipidemias, desirable cholesterol and triglyceride levels can be achieved with a synergy between drug treatment and adequate diet therapy. However, what diets should be adopted? In this review article, different types of dietary treatments are compared, with a special focus on diet education. The new scientific frontier of nutrigenetics is also discussed.

IncidenceCholesterol HDLCholesterol LDLDiet dyslipidemia metabolic syndrome nutrition obesityDiet MediterraneanDietDiet Carbohydrate-RestrictedNutrigenomicsItalyPatient Education as TopicPractice Guidelines as TopicHumansNutrition TherapyDiet Fat-RestrictedLife StyleBiomarkersTriglyceridesDyslipidemias
researchProduct

Clinical Appropriateness of Coronary Angiography

2012

Background: The study evaluates the appropriateness of coronary angiography and the agreement between the used method and the presence of coronary artery disease by the indications proposed from American College of Cardiology/American Heart Association (1999). Method: The guidelines allow us to associate to Class I and IIa the judgment of appropriateness, to the Class IIb of uncertainty; to Class III of inappropriateness. Result: On 761 coronary angiography 76.74% were appropriate, 23.13% unsuitable, 0.13% uncertain. The group with the greater value of appropriateness is that one with unstable angina (97.9% appropriate); that one with the lower value is the group with non-specific symptomat…

Coronary angiographymedicine.medical_specialtybusiness.industryAtherosclerosimedicine.medical_treatmentmedicinePercutaneous coronary interventionLibrary scienceAcute coronary syndromeOmicsbusinessIntensive care medicinePercutaneous coronary interventionJournal of Clinical & Cellular Immunology
researchProduct

The importance of being “not transplantable”

2017

Endstage heart failureMitraClipHeart transplantationLetter to the EditorNYHA functional classMitral regurgitation
researchProduct

Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance

2017

Background. Single-photon emission computed tomography has shown relevant limitations in the quantification of left ventricular (LV) mass. We sought to compare the estimates of LV mass on Cadmium-Zinc-Telluride (CZT) myocardial perfusion imaging (MPI) as compared to cardiac magnetic resonance (CMR). Methods and results. Twenty-five patients underwent MPI on a CZT camera and CMR on a 1.5 T scanner within 12 ± 3 weeks. LV mass was quantified on CZT images using two softwares: 4D-MSPECT (4DM) and Emory Cardiac Toolbox (ECTb). LV mass by CMR was quantified using MASS software (Medis, Leiden, The Netherlands). LV mass values obtained with 4DM and ECTb were highly reproducible [intraclass correla…

MaleIntraclass correlationHeart Ventricles030204 cardiovascular system & hematologyleft ventricular masscardiac magnetic resonance030218 nuclear medicine & medical imagingHeart NeoplasmsLeft ventricular mass03 medical and health sciencesMyocardial perfusion imagingchemistry.chemical_compound0302 clinical medicinePredictive Value of TestsNuclear Medicine and ImagingHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesAged 80 and overTomography Emission-Computed Single-Photonmedicine.diagnostic_testbusiness.industryLimits of agreementMyocardial Perfusion ImagingReproducibility of ResultsCadmium-Zinc-Telluride Æ cardiac magnetic resonance Æ SPECT Æ left ventricular massMiddle AgedMagnetic Resonance ImagingCadmium zinc tellurideZincchemistryCadmium-Zinc-Telluride; cardiac magnetic resonance; left ventricular mass; SPECT; Radiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular MedicineSPECTCadmium-Zinc-TellurideFemaleTelluriumRadiologyCardiology and Cardiovascular MedicineNuclear medicinebusinessCardiac magnetic resonanceEmission computed tomographyCadmiumJournal of Nuclear Cardiology
researchProduct

Helicobacter pylori and atrial fibrillation: absence of correlations

2009

Malemedicine.medical_specialtyRisk AssessmentGastroenterologyHelicobacter InfectionsRisk FactorsInternal medicineAtrial FibrillationmedicineHumansProspective StudiesProspective cohort studyHelicobacter pyloribiologybusiness.industryCase-control studyAtrial fibrillationGeneral MedicineMiddle AgedHelicobacter pylorimedicine.diseaseHelicobacter Infectionsbiology.organism_classificationInflammatory mediatorHelicobacter pylori atrial fibrillationCase-Control StudiesFemaleInflammation MediatorsCardiology and Cardiovascular MedicineRisk assessmentbusinessBiomarkersJournal of Cardiovascular Medicine
researchProduct

Native Mitral Valve Endocarditis Caused by Neisseria elongata subsp. nitroreducens in a Patient with Marfan Syndrome: First Case in Italy and Review …

2016

Neisseria elongata(NE) is an aerobic Gram-negative organism that constitutes part of the commensal human normal oropharyngeal flora. Although previously considered not to be pathogenic, it has been recognized as an occasional cause of significant infections in humans. We report here the first case in Italy of infective endocarditis of a native prolapsing mitral valve in a patient with Marfan syndrome, caused by NE subspeciesnitroreducenswhich has been rarely isolated from clinical specimens. The culprit organism has been confirmed by mass spectrometry directly from the positive blood culture, as previously reported. The amplified gene has been deposited in GenBank under accession number KT5…

0301 basic medicineMarfan syndromePathologymedicine.medical_specialty030106 microbiologyCase Report030204 cardiovascular system & hematologyMicrobiologylcsh:Infectious and parasitic diseases03 medical and health sciencesMitral valve endocarditis0302 clinical medicineMitral valveMedicineEndocarditislcsh:RC109-216Neisseria elongata subsp nitroreducensNeisseria elongatabiologybusiness.industryGeneral MedicineNeisseria elongatabiology.organism_classificationmedicine.diseasemedicine.anatomical_structureInfective endocarditisPositive blood cultureendocarditisbusinessCase Reports in Infectious Diseases
researchProduct

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

2007

The aim of our study was to evaluate, in patients with proven coronary artery disease (CAD) and treated with elective percutaneous coronary intervention (PCI), whether the coexistence of asymptomatic carotid and femoral atherosclerotic lesions would provide prognostic information in terms of occurrence of restenosis.We studied 104 patients with CAD (M/F=77/27), mean age 60.5+/-9 years. All patients were treated with elective PCI. After PCI the suspicion of restenosis was confirmed by coronary angiography. All patients underwent ultrasound duplex scan of carotid and femoral-popliteal-tibial axis to detect atherosclerotic lesions. According to ultrasound results, patients were classified as n…

Malemedicine.medical_specialtymedicine.medical_treatmentBalloonAsymptomaticPeripheral atherosclerosispercutaneous coronary interventionCoronary RestenosisCoronary artery diseaseRestenosisInternal medicineAngioplastymedicineHumanscardiovascular diseasesAngioplasty Balloon CoronaryAgedPeripheral Vascular Diseasesbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedAtherosclerosisPrognosismedicine.diseasePeripheralConventional PCICardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease
researchProduct

Polycitemia vera and pulmonary embolism: case report

2013

Pulmonary embolism is a rare clinical onset of chronic myeloproliferative diseases. Early diagnosis is very important because medical therapy reduces both mortality and morbility. We describe a case of pulmonary embolism as clinical onset of an unknown myeloproliferative disorder. On the basis of our experience is very important early diagnosis and therapy to reduce incidence of later major thrombotic complications.

Malepulmonary embolismPolycitemia veraHumansMiddle AgedPolycythemia VeraSettore MED/11 - Malattie Dell'Apparato Cardiovascolare
researchProduct